Additionally, E-selectin antagonists were also shown to prevent hematogenous metastasis of breast cancer via the inhibition of a shear-resistant adhesion of cancer cells to E-selectin-expressing blood vessels on the PMN [291, 292]. This evidence concerns the gene SELE and breast carcinoma.